BJCM

Blue Jay Capital Management Portfolio holdings

AUM $147M
1-Year Est. Return 64.18%
This Quarter Est. Return
1 Year Est. Return
+64.18%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$203M
AUM Growth
+$37.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
27
New
Increased
Reduced
Closed

Top Buys

1
+$12.7M
2
+$11.8M
3
+$9.53M
4
ABMD
Abiomed Inc
ABMD
+$9.39M
5
NVRO
NEVRO CORP.
NVRO
+$9.37M

Top Sells

1
+$11M
2
+$11M
3
+$10.9M
4
BSX icon
Boston Scientific
BSX
+$10.8M
5
SHPG
Shire pic
SHPG
+$10.6M

Sector Composition

1 Healthcare 78.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSRO
1
DELISTED
TESARO, Inc.
TSRO
$13M 6.4%
84,649
-5,046
BIIB icon
2
Biogen
BIIB
$22.8B
$12.7M 6.23%
+46,320
GMED icon
3
Globus Medical
GMED
$11.3B
$11.8M 5.82%
+400,000
IRWD icon
4
Ironwood Pharmaceuticals
IRWD
$312M
$11.5M 5.66%
805,950
-116,259
QGENF
5
DELISTED
QIAGEN NV
QGENF
$11.3M 5.55%
390,000
-48,572
BMY icon
6
Bristol-Myers Squibb
BMY
$95B
$10.9M 5.35%
200,000
+30,000
CLVS
7
DELISTED
Clovis Oncology, Inc.
CLVS
$9.55M 4.7%
150,000
-148,982
WMGI
8
DELISTED
Wright Medical Group Inc
WMGI
$9.53M 4.68%
+306,165
ABMD
9
DELISTED
Abiomed Inc
ABMD
$9.39M 4.62%
+75,000
NVRO
10
DELISTED
NEVRO CORP.
NVRO
$9.37M 4.61%
+100,000
INCY icon
11
Incyte
INCY
$20.8B
$9.31M 4.58%
69,678
-39,693
BCR
12
DELISTED
CR Bard Inc.
BCR
$9.3M 4.57%
37,419
-14,958
BMRN icon
13
BioMarin Pharmaceuticals
BMRN
$9.89B
$9.22M 4.53%
+105,000
NUVA
14
DELISTED
NuVasive, Inc.
NUVA
$9.21M 4.53%
+123,317
PRAH
15
DELISTED
PRA Health Sciences, Inc.
PRAH
$9.13M 4.49%
+140,000
CELG
16
DELISTED
Celgene Corp
CELG
$9.07M 4.46%
+72,902
VRTX icon
17
Vertex Pharmaceuticals
VRTX
$104B
$8.77M 4.31%
+80,161
EW icon
18
Edwards Lifesciences
EW
$48.4B
$8.47M 4.16%
270,000
-39,087
MDRX
19
DELISTED
Veradigm Inc. Common Stock
MDRX
$7.48M 3.68%
+590,000
AKRX
20
DELISTED
Akorn Inc
AKRX
$7.22M 3.55%
+300,000
DERM
21
DELISTED
Dermira, Inc.
DERM
$7.16M 3.52%
210,000
-140,000
BSX icon
22
Boston Scientific
BSX
$148B
– –
-498,303
HOLX icon
23
Hologic
HOLX
$16.5B
– –
-273,478
LH icon
24
Labcorp
LH
$21B
– –
-98,940
RMD icon
25
ResMed
RMD
$36.7B
– –
-145,000
1
2